Insulet | PODD - Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
AtriCure USD 345.53M 31.84M 2026-06
Avanos Medical USD 325M 30.4M 2026-03
Baxter International USD 6.85B 25M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Cardinal Health USD 38.06B 1.17B 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.33B 298.4M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Globus Medical USD 2.2B 72.51M 2026-03
ICU Medical USD 1.21B 22.69M 2026-03
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.1B 61.62M 2026-03
Roche Holding CHF 35.44B 3.29B 2026-06
Solventum Corp USD 3.58B 276M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
West Pharmaceutical Services USD 1.81B 19.3M 2026-06
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03